SARS-CoV-2 spike IgG titres up to 137 days following Comirnaty mRNA COVID-19 vaccination, Israel, February to May 2021Article Published on 2022-10-012022-11-15 Journal: Eurosurveillance [Category] [DOI] 10.2807/1560-7917.ES.2022.27.40.2100703 PMC 바로가기
Individuals with obesity who survive SARS-CoV-2 infection have preserved antigen-specific T cell frequenciesArticle Published on 2022-10-012022-11-15 Journal: Obesity (Silver Spring, Md.) [Category] [DOI] 10.1002/oby.23526 PMC 바로가기
3’UTR of SARS-CoV-2 spike gene hijack host miR-296 or miR-520h to disturb cell proliferation and cytokine signalingArticle Published on 2022-09-272022-11-16 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.924667 PMC 바로가기
An ACE2-dependent Sarbecovirus in Russian bats is resistant to SARS-CoV-2 vaccinesArticle Published on 2022-09-222022-11-15 Journal: PLoS Pathogens [Category] [DOI] 10.1371/journal.ppat.1010828 PMC 바로가기
Intranasal immunization with recombinant Vaccinia virus encoding trimeric SARS-CoV-2 spike receptor-binding domain induces neutralizing antibodyArticle Published on 2022-09-222022-11-15 Journal: Vaccine [Category] [DOI] 10.1016/j.vaccine.2022.08.054 PMC 바로가기
Metalloprotease-Dependent S2′-Activation Promotes Cell-Cell Fusion and Syncytiation of SARS-CoV-2Article Published on 2022-09-212022-11-16 Journal: Viruses [Category] [DOI] 10.3390/v14102094 PMC 바로가기
A novel delayed lateral flow immunoassay for enhanced detection of SARS-CoV-2 spike antigenArticle Published on 2022-09-202022-11-15 Journal: Mikrochimica Acta [Category] [DOI] 10.1007/s00604-022-05467-3 PMC 바로가기
SARS-CoV-2 infection, vaccination, and antibody response trajectories in adults: a cohort study in CataloniaArticle Published on 2022-09-162022-11-15 Journal: BMC Medicine [Category] [DOI] 10.1186/s12916-022-02547-2 PMC 바로가기
SARS-CoV-2 specific T cell and humoral immune responses upon vaccination with BNT162b2: a 9 months longitudinal studyArticle Published on 2022-09-142022-11-15 Journal: Scientific Reports [Category] [DOI] 10.1038/s41598-022-19581-y PMC 바로가기
Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trialArticle Published on 2022-09-122022-11-15 Journal: Nature Communications [Category] [DOI] 10.1038/s41467-022-33036-y PMC 바로가기